These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5142212)

  • 41. [Botulin toxin for spasticity in spinal cord damage by treating the motor endplate].
    Keren O; Shinberg F; Catz A; Giladi N
    Harefuah; 2000 Feb; 138(3):204-8, 270. PubMed ID: 10883093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrathecal clonidine for controlling spastic hypertonia.
    Rémy-Néris O; Denys P; Bussel B
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):939-51, ix. PubMed ID: 11723871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pharmacotherapy of spinal spasticity: a decade of progress I. Theoretical aspects.
    Segatore M; Miller M
    SCI Nurs; 1994 Aug; 11(3):66-9. PubMed ID: 7792570
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of spasticity with dantrolene sodium.
    Mayer N; Necomber SA; Herman R
    Am J Phys Med; 1973 Feb; 52(1):18-29. PubMed ID: 4685519
    [No Abstract]   [Full Text] [Related]  

  • 45. [Transcutaneous electric stimulation at acupoints in the treatment of spinal spasticity: effects and mechanism].
    Yu Y
    Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):593-5, 637. PubMed ID: 8313180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabis effect on spasticity in spinal cord injury.
    Malec J; Harvey RF; Cayner JJ
    Arch Phys Med Rehabil; 1982 Mar; 63(3):116-8. PubMed ID: 6978699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Changes in the motor units in patients with traumatic paraplegia].
    Khoubesserian P; Telerman-Toppet N; Welraeds D; Coërs C
    Rev Neurol (Paris); 1983; 139(11):635-42. PubMed ID: 6677976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Unexplained paraplegia syndromes: spastic leg].
    Baust W
    Med Welt; 1977 Jul; 28(28):1205-7. PubMed ID: 895455
    [No Abstract]   [Full Text] [Related]  

  • 49. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A therapeutic trial of milacemide in myoclonus and the stiff-person syndrome.
    Brown P; Thompson PD; Rothwell JC; Day BL; Marsden CD
    Mov Disord; 1991; 6(1):73-5. PubMed ID: 2005926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
    Sobolewski P
    Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of patients with sequelae of birth injuries of the spinal cord by euphyllin and nicotinic acid electrophoresis combined with paraffin or ozokerite applications].
    Ratner AU; Molotilova TG; Soldatova LP; Riakina AE
    Vopr Kurortol Fizioter Lech Fiz Kult; 1974; (5):415-8. PubMed ID: 4446427
    [No Abstract]   [Full Text] [Related]  

  • 53. [Local hypothermia in spinal injuries and diseases].
    Iumashev GS; Lavrov IN; Cherkashina ZA
    Ortop Travmatol Protez; 1981 May; (5):67-9. PubMed ID: 7022308
    [No Abstract]   [Full Text] [Related]  

  • 54. [Presentation of a case of spastic paraplegia treated with chemical rhizotomy].
    Durand H; Masson V; D'Amours M
    Laval Med; 1967 Sep; 38(7):647-9. PubMed ID: 5619632
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of neurolax on spasticity in the light of clinical observations].
    Weiss M; Kiwerski J; Rudnicki S; Jedrychowska K
    Pol Tyg Lek; 1969 Jul; 24(28):1095-6. PubMed ID: 4896580
    [No Abstract]   [Full Text] [Related]  

  • 56. [The specific features of clinical manifestations and surgical treatment of spastic and pain syndromes after injury to the vertebral column and spinal cord].
    Dreval' ON; Chernykh IA; Baskov AV; Boev MV; Tsuladze II; Lisitskiĭ IIu
    Zh Vopr Neirokhir Im N N Burdenko; 2007; (3):16-21; discussion 21-2. PubMed ID: 18041207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Myotonolysis by means of orphenadrine citrate. Clinical and electromyographic studies in cerebral and spinal spasticity].
    Steinbrecher W
    Arzneimittelforschung; 1966 Feb; 16(2):147-53. PubMed ID: 6014007
    [No Abstract]   [Full Text] [Related]  

  • 58. [Spasticity in traumatic paraplegia. Electrophysiology study of the initial stage].
    Benezech J
    Neurochirurgie; 1977; 23(5):318-24. PubMed ID: 614498
    [No Abstract]   [Full Text] [Related]  

  • 59. Marihuana as a therapeutic agent for muscle spasm or spasticity.
    Petro DJ
    Psychosomatics; 1980 Jan; 21(1):81, 85. PubMed ID: 7360860
    [No Abstract]   [Full Text] [Related]  

  • 60. Electromyographic investigation of spasticity and muscle spasm.
    Basmajian JV
    Physiotherapy; 1976 Oct; 62(10):319-23. PubMed ID: 790427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.